Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

被引:104
|
作者
Lee, Seung-Yup [1 ]
Lee, Soo-Jung [2 ]
Han, Changsu [3 ]
Patkar, Ashwin A. [4 ]
Masand, Prakash S. [5 ]
Pae, Chi-Un [2 ,4 ]
机构
[1] Catholic Univ Korea, Grad Sch, Dept Med, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Psychiat, Seoul, South Korea
[3] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea
[4] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA
[5] Global Med Educ Inc, New York, NY USA
来源
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2013年 / 46卷
关键词
Antidepressant; Depression; Novel target; Oxidative/nitrosative stress; MAJOR DEPRESSIVE DISORDER; RANDOMIZED CONTROLLED-TRIAL; CHEMOATTRACTANT PROTEIN-1 MCP1; ANTIOXIDANT ENZYME-ACTIVITIES; HEME OXYGENASE-1 EXPRESSION; SUPEROXIDE-DISMUTASE LEVELS; GLYCOGEN-SYNTHASE KINASE-3; KILLER-CELL CYTOTOXICITY; INDUCED OXIDATIVE STRESS; NF-KAPPA-B;
D O I
10.1016/j.pnpbp.2012.09.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The brain is an organ predisposed to oxidative/nitrosative stress. This is especially true in the case of aging as well as several neurodegenerative diseases. Under such circumstances, a decline in the normal antioxidant defense mechanisms leads to an increase in the vulnerability of the brain to the deleterious effects of oxidative damage. Highly reactive oxygen/nitrogen species damage lipids, proteins, and mitochondrial and neuronal genes. Unless antioxidant defenses react appropriately to damage inflicted by radicals, neurons may experience microalteration, microdysfunction, and degeneration. We reviewed how oxidative and nitrosative stresses contribute to the pathogenesis of depressive disorders and reviewed the clinical implications of various antioxidants as future targets for antidepressant treatment. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:224 / 235
页数:12
相关论文
共 50 条
  • [1] Novel Molecular Targets of Antidepressants
    Jaronczyk, Malgorzata
    Walory, Jaroslaw
    MOLECULES, 2022, 27 (02):
  • [2] Advances in novel molecular targets for antidepressants
    Wang, Qingzhong
    Dwivedi, Yogesh
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 104
  • [3] mGlu receptors as potential targets for novel antidepressants
    Chaki, Shigeyuki
    Fukumoto, Kenichi
    CURRENT OPINION IN PHARMACOLOGY, 2018, 38 : 24 - 30
  • [4] Pharmacogenomics in search for novel therapeutic targets for antidepressants
    Yamada, M
    Higuchi, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S60 - S60
  • [5] Emerging role of microRNAs as novel targets of antidepressants
    Manoharan, Aarthi
    Paul, Abialbon
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 66
  • [6] Stress, plasticity, antidepressants: Common synaptic and molecular targets
    Jay, T. M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 42 - 42
  • [7] Functional neuroimaging strategies for assessing novel targets for antidepressants
    Baxter, L. R., Jr.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S37 - S37
  • [8] Potential Targets for the Development of Novel Antidepressants: Future Perspectives
    Thakare, Vishnu N.
    Patel, Bhoomika M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2015, 14 (02) : 270 - 281
  • [9] Molecular and genetic targets for antidepressants
    Kendall, DA
    Hill, SJ
    Richards, JK
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A4 - A4
  • [10] Modified antidepressants as innovative tools for identifying novel drug targets
    Kirmeier, T.
    Ganal, V
    Ranganath, G.
    Flachskamm, C.
    Maccarrone, G.
    Turck, C. W.
    Hausch, F.
    Holsboer, F.
    Rein, T.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 226 - 226